Chapter 130: Management of Thyroid Neoplasms

  1. Which of the following statements regarding medullary thyroid carcinoma is true?
    • A. Multiple endocrine neoplasia type IIa is less aggressive than multiple endocrine neoplasia type IIb.
    • B. Family genetic screening is indicated in all cases.
    • C. Thyroidectomy should be delayed until adolescence in children whose relatives have positive genetic screening.
    • D. All first-degree relatives should have serum calcitonin follow-up regardless of the results of genetic screening.
    • E. Serum calcium should be followed up in both multiple endocrine neoplasia type IIa and multiple endocrine neoplasia type IIb patients.
  2. Thyroid cancer
    • A. does not occur in multinodular goiter.
    • B. is frequently undetectable by palpation.
    • C. constitutes 50% of endocrine malignancies.
    • D. is found as an occult malignancy in 1% of autopsies.
    • E. is more frequent than benign thyroid lesions in irradiated thyroid glands.
  3. Thyroid cancer in an irradiated thyroid gland
    • A. is more likely to occur if the patient is male.
    • B. is more likely to occur if the patient is an adult.
    • C. is more likely to occur if there is a family history of thyroid cancer.
    • D. does not occur if the dose is higher than 2000 Gy.
    • E. does not occur later than 20 years after radiation exposure.
  4. Prognosis of differentiated thyroid cancer is improved by
    • A. male gender.
    • B. coexistent Graves' disease.
    • C. less extensive surgery.
    • D. radioactive iodine therapy.
    • E. thyroid hormone therapy to keep thyroid-stimulating hormone in the high-normal range.
  5. Which of the following statements regarding thyrogloblulin in the follow-up of thyroid cancer is true?
    • A. It is helpful only after total thyroid ablation.
    • B. Readings are adjusted to the amount of antithyroglobulin antibodies present in serum.
    • C. Undetectable thyroglobulin levels exclude tumor recurrence.
    • D. Thyroglobulin levels are affected by estrogen administration.
    • E. Levels should be measured until tests are negative for 3 years.
  6. Radioactive iodine scan in the follow-up of thyroid cancer
    • A. uses iodine-123.
    • B. is not needed if thyroglobulin is undetectable.
    • C. excludes metastasis if it is negative.
    • D. should be repeated after a therapeutic dose even if the diagnostic scan is negative.
    • E. indicates massive liver metastases if there is diffuse hepatic uptake.
  7. Which of the following statements regarding radioactive iodine therapy of thyroid cancer is true?
    • A. It necessitates hospitalization if the dose is 20 mCi or higher.
    • B. It should be done after normalizing thyroid-stimulating hormone levels.
    • C. It is performed following 2 days of a low-iodine diet.
    • D. It is repeated until the tumor no longer concentrates radioactive iodine.
    • E. l-thyroxine is used to control subsequent hypothyroidism.

This is the end of the test. When you have completed all the questions and reviewed your answers, press the button below to grade the test.